Consensus EPS · Q2 2026
$6.58
Consensus revenue · Q2 2026
$1.3B
Analysts
11
Expected report
Aug 5, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 11 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.3B |
| EPS | $6.46 | $6.58 | $6.77 |
| EBITDA | $678.1M | $683.4M | $693.9M |
| EBIT | $567.2M | $571.6M | $580.4M |
| Net income | $442.5M | $450M | $463.7M |
- Revenue$1.3B
- EPS$6.58
- EBITDA$683.4M
- EBIT$571.6M
- Net income$450M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $1.3B | $1.2B | +4.0% | $5.80 | $5.47 | +6.0% |
- Q1 2026+4.0%+6.0%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Corpay (CPAY) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
- Low
- $340.00
- Consensus
- $385.89
- Median
- $385.00
- High
- $450.00
- Current
- $359.00
- Upside
- +7.5%
Upside calculated vs most recent trading price of $359.00.
Analyst ratings
Consensus: Buy — based on 18 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 31, 2026 | Baird | maintain | Outperform | Outperform |
| Feb 10, 2026 | UBS | maintain | Neutral | Neutral |
| Feb 9, 2026 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Feb 6, 2026 | Mizuho | maintain | Neutral | Neutral |
| Feb 5, 2026 | RBC Capital | maintain | Sector Perform | Sector Perform |
| Feb 5, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Feb 5, 2026 | JP Morgan | maintain | Overweight | Overweight |
| Jan 26, 2026 | Morgan Stanley | upgrade | Equal Weight | Overweight |
| Jan 12, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Dec 5, 2025 | Oppenheimer | upgrade | Perform | Outperform |
- Mar 31, 2026BairdOutperform
- Feb 10, 2026UBSNeutral
- Feb 9, 2026Cantor FitzgeraldOverweight
- Feb 6, 2026MizuhoNeutral
- Feb 5, 2026RBC CapitalSector Perform
- Feb 5, 2026Morgan StanleyOverweight
- Feb 5, 2026JP MorganOverweight
- Jan 26, 2026Morgan StanleyOverweight
- Jan 12, 2026OppenheimerOutperform
- Dec 5, 2025OppenheimerOutperform
Frequently asked questions
Corpay (CPAY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.